Print this page    •   Back to Web version of article

Information
Hepatitis C Genotypes

July 23, 2014


What Are Hepatitis C Genotypes?

There are different strain, or genotypes of hepatitis C virus (HCV). Each genotypes’ genes differ somewhat from one another and can be distinguished by laboratory tests. Different HCV genotypes are more common in some parts of the world. The HCV genotypes share some common gene sequences with other genotypes, but differ in others. These variations are adaptations by the virus to different environments and challenges.

HCV multiplies very quickly, making more than 1 trillion copies each day. Many of these new copies are different from the original virus. Many of these mutant versions cannot survive. However, some do survive, even when anti-HCV drugs are used. These mutant versions involve just a few points of the HCV genetic code. They are not genotypes.

Globally, there are 11 HCV genotypes. They are identified by a number, for example genotype 1. There are also subtypes, identified by a letter (for example, genotype 1a.)


Why Do HCV Genotypes Matter?

The different HCV genotypes generally act the same in how they infect people and cause disease. But HCV genotypes respond differently to treatment with pegylated interferon and ribavirin (see Fact Sheet 680.) Treatment with interferon and ribavirin is successful in 70% to 90% of patients with genotypes 2 and 3, but only 40% to 60% of patients with genotype 1.

The subtype of HCV is also important. Some of the new drugs being developed to fight HCV are more effective against genotype 1b rather than 1a.

The variety of HCV genotypes is also important for vaccine development. An effective vaccine will have to produce an immune response to more than one genotype.


Where Are the HCV Genotypes Found?

The different HCV genotypes generally act the same in how they infect people and cause disease. But HCV genotypes respond differently to treatment with HCV medications, like interferon and ribavirin (see fact sheet 680.) Treatment with interferon and ribavirin is successful in 70% to 90% of patients with genotypes 2 and 3, but only 40% to 60% of patients with genotype 1. Newer HCV drugs are more effective against a range of genotypes; sometimes, different treatments are given to people with specific genotypes.

The variety of HCV genotypes is also important for vaccine development. An effective vaccine will have to produce an immune response to more than one genotype.


How Is the Genotype Determined?

A blood sample is tested to determine the HCV genetic sequence. HCV genotype testing is only done once since the genotype does not change.

However, if someone infected with HCV is exposed again, they could be infected with a different genotype.




This article was provided by AIDS InfoNet. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/63253/hepatitis-c-genotypes.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.